Genetic Research of Retinal Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (10 October 2023) | Viewed by 860
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gene-based therapeutics have shown enormous potential for the treatment of inherited and acquired retinal diseases; however, there are some important limitations that need to be acknowledged and addressed in future research. For example, genes implicated in retinal diseases and their related pathophysiologic pathways still need to be elucidated.
The objective of this Special Issue is to provide prospects of currently used and novel genetic testing and diagnoses, gene-based therapeutic strategies, and their applications for retinal diseases.
Genome-editing techniques have shown their potential in the treatment of inherited retinal diseases, which still relies on the identification of appropriate therapeutic targets in disease pathophysiology. Microorganisms have also been shown to play a significant role in retinal diseases. The gut–retina axis may contribute to elucidating previously unknown pathways involved in retinal diseases, presenting a potential therapeutic avenue.
The research areas of this Special Issue may cover functional studies looking at the pathogenicity of disease-related genes rather than only bioinformatic approaches; retinal diseases’ molecular diagnoses and phenotype–genotype correlations; and more sophisticated knowledge of retinal biology and pathophysiology that contributes to the application of gene therapy.
Dr. Ling Zhu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetic testing
- gene therapy
- diagnosis
- pathophysiology
